scientifyRESEARCH
research funding database

RESEARCH FUNDING

Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple Myeloma (USA)

Share this post

Logo of scientifyRESEARCH and Enago "Author First, Quality First" scientifyRESEARCH recommends English editing and author support services from Enago.
Text on a blue background says "Want to find funding & get support for grant-writing?" Logos of scientifyRESEARCH & GrantDesk appear below on a white background and an orange play symbol appears between the two logos. An arrow mark points to the logos.

The Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple Myeloma supports Investigator Sponsored Research (ISR) projects that advance medical and scientific knowledge about Pfizer’s therapies. An ISR is a type of grant that supports an independent research study where the investigator or organization is the sponsor of the study and where Pfizer provides financial and/or non-financial support for the development or refinement of specific and defined medical knowledge relating to a Pfizer asset. This program is open to all researchers who are interested in conducting their own research.

Applicant must be affiliated with academic research institutions in the USA. Applicants may apply for up to 200,000 USD (including 28% indirect costs).

Applications close on August 22, 2024.

Adverts. Premium members do not see Google Ads.

Please Login / Subscribe to our premium membership to see the content. Sign up to Free trial to see detailed funding information.

non member

Sign-up for the
scientifyRESEARCH
monthly funding newsletter

unsubscribe at any time